Search
for
Sort by
Research 181–210 of 1000+
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives
- Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors
- Bladder cancer survival in men using 5-alpha-reductase inhibitors
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Uncovering the complex relationship between balding, testosterone and skin cancers in men
- 5α-Reductase Inhibitors Do Not Prevent the Development and Progression of Urothelial Cancer: In Vitro Evidence
- Investigation on antimicrobial, antioxidant, and anti-cancerous activity of Agaricus bisporus derived β-Glucan against cervical cancer cell line
- Impact of Chemotherapeutic Drug on People living with Cancer
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- Cronkhite-Canada syndrome associated with colon cancer metastatic to liver
- MSF-VMDNet for multi class segmentation of skin cancer whole slide images using a multi frequency dual encoder network
- 643 Male pattern baldness and risk of incident skin cancer in a cohort of men
- Causal associations between plasma proteins and prostate cancer: a Proteome-Wide Mendelian Randomization
- 414 A fitst-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and fluorescence contrast in skin cancer
- Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer
- Retinoids for Chemoprophylaxis of Nonmelanoma Skin Cancer
- Next-Gen Therapeutics for Skin Cancer: Nutraceuticals
- Pantolactams as androgen receptor antagonists for the topical suppression of sebum production
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Pain in pancreatic cancer: A medical oncologist's view
- Malignancy and Cancer Treatment-Related Hair and Nail Changes
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- Risk factors for prostate cancer: a case-control study investigating selected key exposures and their interactions with predisposition genes
- Finasteride does not prevent bladder cancer: A secondary analysis of the Medical Therapy for Prostatic Symptoms Study
- Maternal PPARγ protects nursing neonates by suppressing the production of inflammatory milk
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- Weekly docetaxel in minimally pretreated cancer patients: A dose-escalation study focused on feasibility and cumulative toxicity of long-term administration